InflaRx Accounts Payable vs Net Debt Analysis

IFRX Stock  USD 2.37  0.13  5.20%   
InflaRx NV financial indicator trend analysis is infinitely more than just investigating InflaRx NV recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether InflaRx NV is a good investment. Please check the relationship between InflaRx NV Accounts Payable and its Net Debt accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InflaRx NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy InflaRx Stock please use our How to Invest in InflaRx NV guide.

Accounts Payable vs Net Debt

Accounts Payable vs Net Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of InflaRx NV Accounts Payable account and Net Debt. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between InflaRx NV's Accounts Payable and Net Debt is -0.14. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Net Debt in the same time period over historical financial statements of InflaRx NV, assuming nothing else is changed. The correlation between historical values of InflaRx NV's Accounts Payable and Net Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of InflaRx NV are associated (or correlated) with its Net Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Debt has no effect on the direction of Accounts Payable i.e., InflaRx NV's Accounts Payable and Net Debt go up and down completely randomly.

Correlation Coefficient

-0.14
Relationship DirectionNegative 
Relationship StrengthInsignificant

Accounts Payable

An accounting item on the balance sheet that represents InflaRx NV obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of InflaRx NV are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.
Most indicators from InflaRx NV's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into InflaRx NV current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InflaRx NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy InflaRx Stock please use our How to Invest in InflaRx NV guide.Sales General And Administrative To Revenue is likely to rise to 212.95 in 2025, whereas Selling General Administrative is likely to drop slightly above 10.1 M in 2025.

InflaRx NV fundamental ratios Correlations

-0.770.570.840.990.680.990.77-0.53-0.740.750.530.510.230.980.620.950.47-0.77-0.770.420.490.91-0.510.470.59
-0.77-0.48-0.7-0.84-0.55-0.84-0.680.310.67-0.64-0.31-0.41-0.2-0.74-0.54-0.83-0.391.01.0-0.36-0.48-0.780.9-0.39-0.52
0.57-0.480.810.540.320.570.850.09-0.810.34-0.090.84-0.180.410.550.650.79-0.5-0.490.370.930.76-0.150.80.58
0.84-0.70.810.810.510.820.97-0.1-0.930.750.10.76-0.10.720.750.910.79-0.71-0.710.540.710.96-0.330.710.76
0.99-0.840.540.810.681.00.74-0.55-0.720.730.550.470.270.980.590.960.43-0.85-0.840.380.470.9-0.630.430.56
0.68-0.550.320.510.680.680.5-0.08-0.430.520.070.23-0.320.690.440.590.36-0.54-0.540.230.240.56-0.410.210.37
0.99-0.840.570.821.00.680.76-0.54-0.730.720.540.470.270.970.580.960.45-0.85-0.840.370.510.91-0.620.420.55
0.77-0.680.850.970.740.50.760.02-0.920.69-0.010.72-0.210.640.690.860.78-0.69-0.680.450.810.91-0.320.660.7
-0.530.310.09-0.1-0.55-0.08-0.540.02-0.03-0.14-1.00.05-0.88-0.630.11-0.410.360.30.310.140.09-0.240.350.070.13
-0.740.67-0.81-0.93-0.72-0.43-0.73-0.92-0.03-0.780.04-0.660.16-0.62-0.87-0.83-0.840.690.68-0.69-0.75-0.930.32-0.65-0.87
0.75-0.640.340.750.730.520.720.69-0.14-0.780.130.25-0.030.730.870.750.57-0.64-0.640.760.260.79-0.380.270.85
0.53-0.31-0.090.10.550.070.54-0.01-1.00.040.13-0.050.880.63-0.130.41-0.36-0.3-0.31-0.16-0.080.24-0.35-0.07-0.15
0.51-0.410.840.760.470.230.470.720.05-0.660.25-0.05-0.140.330.470.550.65-0.43-0.420.330.680.64-0.080.980.51
0.23-0.2-0.18-0.10.27-0.320.27-0.21-0.880.16-0.030.88-0.140.31-0.190.17-0.41-0.2-0.2-0.1-0.170.05-0.34-0.14-0.17
0.98-0.740.410.720.980.690.970.64-0.63-0.620.730.630.330.310.530.90.3-0.74-0.740.330.350.82-0.540.30.48
0.62-0.540.550.750.590.440.580.690.11-0.870.87-0.130.47-0.190.530.640.79-0.55-0.540.940.410.77-0.250.530.99
0.95-0.830.650.910.960.590.960.86-0.41-0.830.750.410.550.170.90.640.57-0.84-0.840.410.620.96-0.560.490.61
0.47-0.390.790.790.430.360.450.780.36-0.840.57-0.360.65-0.410.30.790.57-0.4-0.390.690.630.76-0.060.610.8
-0.771.0-0.5-0.71-0.85-0.54-0.85-0.690.30.69-0.64-0.3-0.43-0.2-0.74-0.55-0.84-0.41.0-0.36-0.49-0.790.89-0.4-0.53
-0.771.0-0.49-0.71-0.84-0.54-0.84-0.680.310.68-0.64-0.31-0.42-0.2-0.74-0.54-0.84-0.391.0-0.36-0.48-0.790.9-0.39-0.52
0.42-0.360.370.540.380.230.370.450.14-0.690.76-0.160.33-0.10.330.940.410.69-0.36-0.360.180.58-0.140.420.95
0.49-0.480.930.710.470.240.510.810.09-0.750.26-0.080.68-0.170.350.410.620.63-0.49-0.480.180.67-0.20.640.43
0.91-0.780.760.960.90.560.910.91-0.24-0.930.790.240.640.050.820.770.960.76-0.79-0.790.580.67-0.470.580.76
-0.510.9-0.15-0.33-0.63-0.41-0.62-0.320.350.32-0.38-0.35-0.08-0.34-0.54-0.25-0.56-0.060.890.9-0.14-0.2-0.47-0.07-0.22
0.47-0.390.80.710.430.210.420.660.07-0.650.27-0.070.98-0.140.30.530.490.61-0.4-0.390.420.640.58-0.070.57
0.59-0.520.580.760.560.370.550.70.13-0.870.85-0.150.51-0.170.480.990.610.8-0.53-0.520.950.430.76-0.220.57
Click cells to compare fundamentals

InflaRx NV Account Relationship Matchups

InflaRx NV fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets88.2M125.1M102.4M120.2M138.2M106.8M
Short Long Term Debt Total559.0K1.4M1.4M1.1M1.0M957.6K
Other Current Liab117.7K8.4M7.7M4.5M5.2M2.8M
Total Current Liabilities10.1M18.8M13.0M16.8M19.4M10.7M
Total Stockholder Equity77.9M105.3M88.3M102.7M118.1M86.6M
Other Liab67.9K39.0K33.3K35.0K40.3K37.6K
Net Tangible Assets151.2M106.7M77.5M105.0M120.8M81.2M
Property Plant And Equipment Net955.0K1.7M1.6M1.4M1.6M988.9K
Net Debt(25.4M)(24.8M)(14.9M)(11.6M)(13.4M)(14.1M)
Retained Earnings(168.3M)(214.0M)(243.5M)(286.1M)(257.5M)(244.6M)
Accounts Payable8.3M1.7M5.0M12.0M13.8M14.5M
Cash26.0M26.2M16.3M12.8M11.5M10.9M
Non Current Assets Total1.9M29.5M5.0M10.7M12.4M6.3M
Non Currrent Assets Other353.5K336.6K308.1K283.2K325.7K381.2K
Other Assets(2.0)353.5K336.6K(8.9K)(8.0K)(7.6K)
Cash And Short Term Investments81.1M83.4M81.8M90.3M103.8M93.4M
Net Receivables1.4M1.3M1.4M3.8M4.4M4.6M
Common Stock Shares Outstanding27.1M41.6M44.2M54.9M63.2M33.6M
Short Term Investments55.2M57.2M65.5M77.5M89.1M53.6M
Liabilities And Stockholders Equity88.2M125.1M102.4M120.2M138.2M106.8M
Non Current Liabilities Total253.8K1.1M1.0M782.6K704.3K669.1K
Capital Lease Obligations559.0K1.4M1.4M1.1M1.3M649.5K
Other Current Assets3.7M11.0M14.2M4.0M4.6M4.3M
Other Stockholder Equity216.6M283.4M289.8M341.7M392.9M210.9M
Total Liab10.4M19.9M14.1M17.6M15.9M14.7M
Long Term Investments272.3K27.2M2.9M9.1M10.4M10.9M
Property Plant And Equipment Gross955.0K1.7M1.6M4.3M5.0M5.2M
Total Current Assets86.3M95.7M97.4M109.5M125.9M100.6M
Accumulated Other Comprehensive Income26.3M30.6M36.6M40.1M36.0M30.9M
Non Current Liabilities Other(1.0)33.3K35.0K36.9K42.4K44.5K
Short Term Debt338.5K366.2K369.4K374.3K430.5K275.1K
Intangible Assets350.2K235.2K138.9K42.8K49.3K46.8K
Common Stock3.4M5.3M5.4M7.1M8.1M8.5M
Property Plant Equipment624.7K1.4M955.0K1.7M1.9M2.0M
Net Invested Capital77.9M105.3M88.3M102.6M92.3M85.9M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for InflaRx Stock Analysis

When running InflaRx NV's price analysis, check to measure InflaRx NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InflaRx NV is operating at the current time. Most of InflaRx NV's value examination focuses on studying past and present price action to predict the probability of InflaRx NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InflaRx NV's price. Additionally, you may evaluate how the addition of InflaRx NV to your portfolios can decrease your overall portfolio volatility.